Symbols / COR Stock $308.60 -1.09% Cencora, Inc.

Healthcare • Medical Distribution • United States • NYQ
COR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Dr. Robert P. Mauch Ph.D., PharmD
Exch · Country NYQ · United States
Market Cap 60.03B
Enterprise Value 69.03B
Income 1.63B
Sales 325.78B
FCF (ttm) 3.46B
Book/sh 9.81
Cash/sh 9.01
Employees 47,000
Insider 10d —
IPO Apr 04, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 27.01%
P/E 37.05
Forward P/E 15.75
PEG 0.73
P/S 0.18
P/B 31.46
P/C —
EV/EBITDA 13.91
EV/Sales 0.21
Quick Ratio 0.47
Current Ratio 0.92
Debt/Eq 472.58
LT Debt/Eq —
EPS (ttm) 8.33
EPS next Y 19.59
EPS Growth 14.80%
Revenue Growth 5.50%
EPS Gr Q/Q 14.50%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-04
ROA 3.33%
ROE 133.47%
ROIC —
Gross Margin 3.61%
Oper. Margin 1.18%
Profit Margin 0.50%
Shs Outstand 194.53M
Shs Float 183.99M
Insider Own 4.23%
Instit Own 96.75%
Short Float 2.83%
Short Ratio 3.08
Short Interest 4.84M
52W High 377.54
vs 52W High -18.26%
52W Low 271.00
vs 52W Low 13.87%
Beta 0.72
Impl. Vol. 0.39%
Rel Volume 0.04
Avg Volume 1.40M
Volume 61.77K
Target (mean) $402.92
Tgt Median $407.50
Tgt Low $340.00
Tgt High $447.00
# Analysts 12
Recom Buy
Prev Close $311.99
Price $308.60
Change -1.09%
About

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$402.92
Mean price target
2. Current target
$308.60
Latest analyst target
3. DCF / Fair value
$320.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$308.60
Low
$340.00
High
$447.00
Mean
$402.92

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-28 init William Blair — → Market Perform —
2026-04-08 main Evercore ISI Group Outperform → Outperform $360
2026-02-13 main Barclays Overweight → Overweight $425
2026-02-10 main JP Morgan Overweight → Overweight $419
2026-02-10 main Wells Fargo Overweight → Overweight $429
2026-02-05 main Evercore ISI Group Outperform → Outperform $420
2026-01-29 up Morgan Stanley Equal-Weight → Overweight $400
2026-01-22 up Jefferies Hold → Buy $440
2026-01-05 main B of A Securities Neutral → Neutral $360
2025-12-09 init Barclays — → Overweight $400
2025-11-11 main JP Morgan Overweight → Overweight $417
2025-11-11 main Wells Fargo Overweight → Overweight $405
2025-11-10 main TD Cowen Buy → Buy $400
2025-11-07 main UBS Buy → Buy $415
2025-11-06 main Baird Outperform → Outperform $395
2025-11-06 main Mizuho Outperform → Outperform $380
2025-10-30 main Mizuho Outperform → Outperform $340
2025-10-27 main UBS Buy → Buy $380
2025-10-16 main Mizuho Outperform → Outperform $334
2025-08-13 main Wells Fargo Overweight → Overweight $354
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-11 CLEARY JAMES F. JR. Chief Financial Officer — 12,623 — —
2026-03-11 BATTAGLIA SILVANA Officer — 8,415 — —
2026-03-11 CAMPBELL ELIZABETH S Officer — 12,623 — —
2026-03-05 TYLER LAUREN M. Director — 641 $359.22 $230,293
2026-03-05 GREENBERG LON R Director — 557 $359.28 $200,119
2026-03-05 DURCAN DERMOT MARK Director — 905 $359.28 $325,148
2026-03-05 COOPER ELLEN Director — 692 $359.22 $248,614
2026-03-05 RYERKERK LORI J Director — 557 $359.28 $200,119
2026-03-05 MILLER REDONDA M.D. Director — 557 $359.28 $200,119
2026-03-05 NALLY DENNIS M Director — 655 $359.22 $235,323
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
321,332.82
+9.31%
293,958.60
+12.12%
262,173.41
+9.89%
238,587.01
Operating Revenue
321,332.82
+9.31%
293,958.60
+12.12%
262,173.41
+9.89%
238,587.01
Cost Of Revenue
309,854.28
+9.08%
284,048.57
+12.18%
253,213.92
+9.95%
230,290.64
Reconciled Cost Of Revenue
309,836.94
+9.09%
284,021.70
+12.17%
253,196.97
+9.95%
230,274.70
Gross Profit
11,478.54
+15.83%
9,910.03
+10.61%
8,959.49
+7.99%
8,296.37
Operating Expense
7,544.92
+11.73%
6,753.08
+7.64%
6,273.89
+13.19%
5,542.86
Selling General And Administration
6,493.84
+14.71%
5,661.11
+6.61%
5,309.98
+9.51%
4,848.96
Total Expenses
317,399.20
+9.15%
290,801.65
+12.07%
259,487.81
+10.03%
235,833.50
Operating Income
3,933.62
+24.60%
3,156.95
+17.55%
2,685.61
-2.47%
2,753.51
Total Operating Income As Reported
2,628.60
+20.84%
2,175.25
-7.07%
2,340.73
-1.08%
2,366.38
EBITDA
3,746.51
+11.12%
3,371.50
+0.03%
3,370.61
+8.60%
3,103.57
Normalized EBITDA
5,051.53
+16.04%
4,353.20
+17.16%
3,715.49
+6.44%
3,490.70
Reconciled Depreciation
1,068.42
-4.51%
1,118.84
+14.07%
980.85
+38.18%
709.84
EBIT
2,678.09
+18.89%
2,252.66
-5.74%
2,389.77
-0.17%
2,393.73
Total Unusual Items
-1,305.02
-32.93%
-981.70
-184.65%
-344.87
+10.92%
-387.13
Total Unusual Items Excluding Goodwill
-1,305.02
-32.93%
-981.70
-184.65%
-344.87
+10.92%
-387.13
Special Income Charges
-1,305.02
-32.93%
-981.70
-184.65%
-344.87
+10.92%
-387.13
Other Special Charges
60.67
-73.28%
227.07
+1019.57%
-24.69
-120.04%
123.19
Impairment Of Capital Assets
723.88
+73.18%
418.00
0.00
-100.00%
75.94
Restructuring And Mergern Acquisition
520.47
+54.61%
336.63
-8.91%
369.57
+101.88%
183.06
Write Off
—
0.00
0.00
-100.00%
4.95
Net Income
1,554.17
+2.99%
1,509.12
-13.53%
1,745.29
+2.74%
1,698.82
Pretax Income
2,258.34
+12.69%
2,003.97
-7.26%
2,160.84
-1.02%
2,183.06
Net Non Operating Interest Income Expense
-291.55
-85.71%
-156.99
+31.42%
-228.93
-8.67%
-210.67
Interest Expense Non Operating
419.75
+68.79%
248.68
+8.63%
228.93
+8.67%
210.67
Net Interest Income
-291.55
-85.71%
-156.99
+31.42%
-228.93
-8.67%
-210.67
Interest Expense
419.75
+68.79%
248.68
+8.63%
228.93
+8.67%
210.67
Interest Income Non Operating
128.21
+39.82%
91.69
+96.26%
46.72
+119.25%
21.31
Interest Income
128.21
+39.82%
91.69
+96.26%
46.72
+119.25%
21.31
Other Income Expense
-1,383.74
-38.93%
-995.98
-236.66%
-295.84
+17.77%
-359.78
Other Non Operating Income Expenses
-78.72
-451.12%
-14.28
-129.13%
49.04
+79.28%
27.35
Tax Provision
690.52
+42.46%
484.70
+13.18%
428.26
-17.09%
516.52
Tax Rate For Calcs
0.00
+26.42%
0.00
+22.16%
0.00
-16.46%
0.00
Tax Effect Of Unusual Items
-399.03
-68.05%
-237.44
-247.72%
-68.29
+25.58%
-91.75
Net Income Including Noncontrolling Interests
1,567.81
+3.20%
1,519.27
-12.31%
1,732.58
+3.96%
1,666.54
Net Income From Continuing Operation Net Minority Interest
1,554.17
+2.99%
1,509.12
-13.53%
1,745.29
+2.74%
1,698.82
Net Income From Continuing And Discontinued Operation
1,554.17
+2.99%
1,509.12
-13.53%
1,745.29
+2.74%
1,698.82
Net Income Continuous Operations
1,567.81
+3.20%
1,519.27
-12.31%
1,732.58
+3.96%
1,666.54
Minority Interests
-13.64
-34.39%
-10.15
-179.84%
12.72
-60.60%
32.28
Normalized Income
2,460.16
+9.18%
2,253.38
+11.45%
2,021.88
+1.39%
1,994.20
Net Income Common Stockholders
1,554.17
+2.99%
1,509.12
-13.53%
1,745.29
+2.74%
1,698.82
Diluted EPS
7.96
+5.71%
7.53
-11.72%
8.53
+6.09%
8.04
Basic EPS
8.02
+5.53%
7.60
-11.83%
8.62
+5.77%
8.15
Basic Average Shares
193.82
-2.36%
198.50
-1.98%
202.51
-2.86%
208.47
Diluted Average Shares
195.21
-2.53%
200.28
-2.11%
204.59
-3.13%
211.21
Diluted NI Availto Com Stockholders
1,554.17
+2.99%
1,509.12
-13.53%
1,745.29
+2.74%
1,698.82
Amortization
556.93
-16.06%
663.47
+19.86%
553.56
+80.14%
307.30
Amortization Of Intangibles Income Statement
556.93
-16.06%
663.47
+19.86%
553.56
+80.14%
307.30
Depreciation Amortization Depletion Income Statement
1,051.08
-3.75%
1,091.97
+13.29%
963.90
+38.91%
693.89
Depreciation And Amortization In Income Statement
1,051.08
-3.75%
1,091.97
+13.29%
963.90
+38.91%
693.89
Depreciation Income Statement
494.14
+15.32%
428.50
+4.43%
410.34
+6.14%
386.60
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
76,590.11
+14.14%
67,101.67
+7.26%
62,558.75
+10.60%
56,560.62
Current Assets
52,239.07
+9.47%
47,717.81
+11.49%
42,798.83
+8.11%
39,589.76
Cash Cash Equivalents And Short Term Investments
4,356.14
+39.06%
3,132.65
+20.86%
2,592.05
-23.50%
3,388.19
Cash And Cash Equivalents
4,356.14
+39.06%
3,132.65
+20.86%
2,592.05
-23.50%
3,388.19
Receivables
25,225.30
+5.67%
23,871.81
+13.74%
20,988.20
+12.69%
18,625.24
Accounts Receivable
25,225.30
+5.67%
23,871.81
+14.16%
20,911.08
+13.32%
18,452.67
Gross Accounts Receivable
27,021.47
+7.31%
25,179.83
+12.69%
22,344.48
+11.28%
20,079.40
Allowance For Doubtful Accounts Receivable
-1,796.17
-37.32%
-1,308.02
+8.75%
-1,433.40
+11.88%
-1,626.73
Taxes Receivable
—
88.23
+14.40%
77.12
-55.31%
172.57
Inventory
20,492.48
+7.86%
18,998.83
+8.85%
17,454.77
+12.20%
15,556.39
Prepaid Assets
—
—
—
487.87
Assets Held For Sale Current
—
—
—
0.00
Other Current Assets
2,165.16
+26.28%
1,714.52
-2.79%
1,763.81
-12.68%
2,019.93
Total Non Current Assets
24,351.04
+25.63%
19,383.85
-1.90%
19,759.92
+16.43%
16,970.86
Net PPE
2,539.08
+16.40%
2,181.41
+2.17%
2,135.17
+0.01%
2,135.00
Gross PPE
5,733.32
+9.94%
5,215.09
+10.04%
4,739.09
+8.02%
4,387.35
Accumulated Depreciation
-3,194.24
-5.29%
-3,033.68
-16.50%
-2,603.92
-15.61%
-2,252.34
Properties
0.00
0.00
0.00
0.00
Land And Improvements
125.00
+6.72%
117.13
+0.57%
116.47
-4.87%
122.43
Buildings And Improvements
1,128.43
+26.27%
893.69
+6.88%
836.17
-0.56%
840.85
Machinery Furniture Equipment
4,479.89
+6.56%
4,204.27
+11.03%
3,786.45
+10.58%
3,424.07
Goodwill And Other Intangible Assets
17,450.70
+31.02%
13,319.07
-4.90%
14,005.90
+9.11%
12,836.62
Goodwill
13,676.52
+46.77%
9,318.03
-2.67%
9,574.12
+12.59%
8,503.89
Other Intangible Assets
3,774.18
-5.67%
4,001.05
-9.72%
4,431.78
+2.29%
4,332.74
Non Current Deferred Assets
208.81
-15.24%
246.35
+22.76%
200.67
-15.53%
237.57
Non Current Deferred Taxes Assets
208.81
-15.24%
246.35
+22.76%
200.67
-15.53%
237.57
Other Non Current Assets
4,152.45
+14.17%
3,637.02
+6.40%
3,418.18
+94.03%
1,761.66
Total Liabilities Net Minority Interest
74,843.03
+12.86%
66,314.93
+7.15%
61,892.46
+9.56%
56,489.34
Current Liabilities
57,820.54
+6.53%
54,277.05
+11.15%
48,831.20
+12.31%
43,477.96
Payables And Accrued Expenses
57,702.75
+7.45%
53,700.72
+11.44%
48,189.85
+13.64%
42,407.48
Payables
54,719.76
+7.42%
50,942.16
+11.14%
45,836.04
+14.04%
40,192.89
Accounts Payable
54,719.76
+7.42%
50,942.16
+11.14%
45,836.04
+14.04%
40,192.89
Current Accrued Expenses
2,982.99
+8.14%
2,758.56
+17.20%
2,353.82
+6.29%
2,214.59
Current Debt And Capital Lease Obligation
117.78
-79.56%
576.33
-10.14%
641.34
-40.09%
1,070.47
Current Debt
117.78
-79.56%
576.33
-10.14%
641.34
-40.09%
1,070.47
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
17,022.49
+41.41%
12,037.87
-7.84%
13,061.26
+0.38%
13,011.39
Long Term Debt And Capital Lease Obligation
7,542.99
+97.89%
3,811.74
-8.06%
4,146.11
-10.50%
4,632.36
Long Term Debt
7,542.99
+97.89%
3,811.74
-8.06%
4,146.11
-10.50%
4,632.36
Tradeand Other Payables Non Current
337.63
+15.71%
291.80
-6.08%
310.68
-3.00%
320.27
Non Current Deferred Liabilities
1,620.72
-1.40%
1,643.75
-0.86%
1,657.94
+2.32%
1,620.41
Non Current Deferred Taxes Liabilities
1,620.72
-1.40%
1,643.75
-0.86%
1,657.94
+2.32%
1,620.41
Other Non Current Liabilities
3,639.86
+82.57%
1,993.68
+5.78%
1,884.73
+92.99%
976.58
Stockholders Equity
1,508.02
+133.46%
645.94
+23.74%
522.00
+346.74%
-211.56
Common Stock Equity
1,508.02
+133.46%
645.94
+23.74%
522.00
+346.74%
-211.56
Capital Stock
2.97
+0.41%
2.96
+0.47%
2.95
+0.72%
2.93
Common Stock
2.97
+0.41%
2.96
+0.47%
2.95
+0.72%
2.93
Share Issued
297.40
+0.42%
296.17
+0.46%
294.82
+0.73%
292.70
Ordinary Shares Number
193.94
-0.52%
194.94
-2.92%
200.81
-2.61%
206.20
Treasury Shares Number
103.46
+2.21%
101.23
+7.68%
94.01
+8.68%
86.50
Additional Paid In Capital
6,204.30
+2.88%
6,030.79
+3.19%
5,844.58
+3.28%
5,658.73
Retained Earnings
6,534.23
+20.62%
5,417.14
+25.28%
4,324.19
+45.22%
2,977.65
Gains Losses Not Affecting Retained Earnings
-901.38
+8.87%
-989.12
+29.48%
-1,402.61
+23.40%
-1,830.97
Treasury Stock
10,332.11
+5.26%
9,815.83
+19.02%
8,247.10
+17.48%
7,019.90
Minority Interest
239.07
+69.79%
140.80
-2.41%
144.28
-48.99%
282.83
Other Equity Adjustments
-901.38
+8.87%
-989.12
+29.48%
-1,402.61
+23.40%
-1,830.97
Total Equity Gross Minority Interest
1,747.09
+122.07%
786.74
+18.08%
666.29
+834.84%
71.27
Total Capitalization
9,051.01
+103.04%
4,457.68
-4.51%
4,668.12
+5.59%
4,420.80
Working Capital
-5,581.47
+14.91%
-6,559.24
-8.73%
-6,032.37
-55.15%
-3,888.20
Invested Capital
9,168.79
+82.14%
5,034.01
-5.19%
5,309.46
-3.31%
5,491.27
Total Debt
7,660.77
+74.58%
4,388.08
-8.34%
4,787.46
-16.05%
5,702.83
Net Debt
3,304.64
+163.23%
1,255.43
-42.82%
2,195.41
-5.15%
2,314.64
Net Tangible Assets
-15,942.68
-25.80%
-12,673.14
+6.01%
-13,483.90
-3.34%
-13,048.18
Tangible Book Value
-15,942.68
-25.80%
-12,673.14
+6.01%
-13,483.90
-3.34%
-13,048.18
Non Current Accrued Expenses
3,881.28
-9.67%
4,296.90
-15.11%
5,061.80
-7.32%
5,461.76
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
3,875.12
+11.20%
3,484.68
-10.91%
3,911.33
+44.70%
2,703.09
Cash Flow From Continuing Operating Activities
3,875.12
+11.20%
3,484.68
-10.91%
3,911.33
+44.70%
2,703.09
Net Income From Continuing Operations
1,567.81
+3.20%
1,519.27
-12.31%
1,732.58
+3.96%
1,666.54
Depreciation Amortization Depletion
1,068.42
-4.51%
1,118.84
+14.07%
980.85
+38.18%
709.84
Depreciation
501.31
+11.85%
448.20
+7.01%
418.83
+7.22%
390.64
Amortization Cash Flow
567.11
-15.44%
670.64
+19.33%
562.02
+76.08%
319.19
Depreciation And Amortization
1,068.42
-4.51%
1,118.84
+14.07%
980.85
+38.18%
709.84
Amortization Of Intangibles
567.11
-15.44%
670.64
+19.33%
562.02
+76.08%
319.19
Other Non Cash Items
-35.35
-230.11%
27.17
-91.07%
304.13
+132.30%
130.92
Stock Based Compensation
147.96
-0.02%
148.00
+18.76%
124.62
+33.43%
93.40
Provisionand Write Offof Assets
63.31
+55.03%
40.83
-24.92%
54.39
+108.76%
26.05
Asset Impairment Charge
837.38
+100.33%
418.00
0.00
-100.00%
80.88
Deferred Tax
59.86
+158.50%
-102.32
+13.92%
-118.86
-160.59%
196.18
Deferred Income Tax
59.86
+158.50%
-102.32
+13.92%
-118.86
-160.59%
196.18
Operating Gains Losses
130.31
+704.33%
16.20
+139.60%
-40.91
+33.01%
-61.06
Change In Working Capital
35.42
-88.14%
298.69
-65.85%
874.54
+726.18%
-139.66
Change In Receivables
-1,923.41
+30.92%
-2,784.34
-2.68%
-2,711.79
-68.41%
-1,610.22
Changes In Account Receivables
-1,923.41
+30.92%
-2,784.34
-2.68%
-2,711.79
-63.41%
-1,659.53
Change In Inventory
-1,269.43
+14.20%
-1,479.60
+32.23%
-2,183.37
-228.14%
-665.37
Change In Prepaid Assets
173.86
+10.97%
156.67
-25.83%
211.24
+105.67%
102.71
Change In Payables And Accrued Expense
3,458.51
-29.59%
4,912.11
-17.56%
5,958.42
+135.19%
2,533.41
Change In Accrued Expense
-21.13
-114.23%
148.53
+190.60%
51.11
+111.18%
-457.23
Change In Payable
3,479.64
-26.95%
4,763.58
-19.36%
5,907.31
+97.53%
2,990.65
Change In Account Payable
3,693.36
-25.66%
4,968.09
-18.60%
6,103.45
+83.80%
3,320.72
Change In Other Current Liabilities
-404.10
+20.16%
-506.15
-26.55%
-399.96
+20.04%
-500.19
Investing Cash Flow
-4,977.29
-705.26%
-618.10
+76.25%
-2,602.47
-606.35%
-368.44
Cash Flow From Continuing Investing Activities
-4,977.29
-705.26%
-618.10
+76.25%
-2,602.47
-606.35%
-368.44
Net PPE Purchase And Sale
—
—
—
6.30
Sale Of PPE
—
—
—
6.30
Capital Expenditure
-667.98
-37.11%
-487.17
-6.29%
-458.36
+7.65%
-496.32
Capital Expenditure Reported
-667.98
-37.11%
-487.17
-6.29%
-458.36
+7.65%
-496.32
Net Business Purchase And Sale
-4,291.87
-4183.26%
-100.20
+95.35%
-2,153.11
-1890.07%
120.28
Purchase Of Business
-4,291.87
-4183.26%
-100.20
+95.35%
-2,153.11
-1313.68%
-152.31
Gain Loss On Sale Of Business
22.70
0.00
+100.00%
-40.66
+27.68%
-56.23
Net Other Investing Changes
-17.44
+43.23%
-30.72
-441.20%
9.00
+18.47%
7.60
Financing Cash Flow
2,249.11
+196.49%
-2,330.99
-4.89%
-2,222.28
-26.79%
-1,752.78
Cash Flow From Continuing Financing Activities
2,249.11
+196.49%
-2,330.99
-4.89%
-2,222.28
-26.79%
-1,752.78
Net Issuance Payments Of Debt
3,195.67
+929.07%
-385.45
+38.16%
-623.26
+32.48%
-923.10
Issuance Of Debt
136,642.71
+94.12%
70,391.37
-10.19%
78,375.99
+1471.36%
4,987.79
Repayment Of Debt
-133,447.04
-88.55%
-70,776.82
+10.41%
-78,999.24
-1236.50%
-5,910.90
Long Term Debt Issuance
4,508.48
+555.00%
688.32
+336.90%
157.55
+1.52%
155.19
Long Term Debt Payments
-1,280.62
-93.29%
-662.52
+18.34%
-811.35
+34.51%
-1,238.95
Net Long Term Debt Issuance
3,227.87
+12413.05%
25.80
+103.95%
-653.81
+39.67%
-1,083.77
Short Term Debt Issuance
132,134.22
+89.57%
69,703.04
-10.89%
78,218.44
+1518.56%
4,832.60
Short Term Debt Payments
-132,166.42
-88.50%
-70,114.29
+10.33%
-78,187.89
-1573.56%
-4,671.94
Net Short Term Debt Issuance
-32.20
+92.17%
-411.25
-1446.24%
30.55
-80.99%
160.66
Net Common Stock Issuance
-435.47
+70.80%
-1,491.37
-26.31%
-1,180.73
-144.10%
-483.70
Common Stock Payments
-435.47
+70.80%
-1,491.37
-26.31%
-1,180.73
-144.10%
-483.70
Common Stock Dividend Paid
-437.08
-5.03%
-416.17
-4.37%
-398.75
-1.80%
-391.69
Cash Dividends Paid
-437.08
-5.03%
-416.17
-4.37%
-398.75
-1.80%
-391.69
Repurchase Of Capital Stock
-435.47
+70.80%
-1,491.37
-26.31%
-1,180.73
-144.10%
-483.70
Proceeds From Stock Option Exercised
29.13
-23.01%
37.84
-38.12%
61.15
-34.88%
93.91
Net Other Financing Charges
-103.14
-35.98%
-75.85
+6.00%
-80.69
-67.42%
-48.20
Changes In Cash
1,146.94
+114.14%
535.60
+158.64%
-913.41
-256.98%
581.87
Effect Of Exchange Rate Changes
-50.27
-635.04%
9.40
-87.09%
72.76
+225.77%
-57.85
Beginning Cash Position
3,297.88
+19.80%
2,752.89
-23.39%
3,593.54
+17.05%
3,070.13
End Cash Position
4,394.55
+33.25%
3,297.88
+19.80%
2,752.89
-23.39%
3,593.54
Free Cash Flow
3,207.14
+6.99%
2,997.51
-13.19%
3,452.97
+56.47%
2,206.77
Change In Income Tax Payable
-213.72
-4.50%
-204.52
-4.27%
-196.15
+40.58%
-330.08
Change In Tax Payable
-213.72
-4.50%
-204.52
-4.27%
-196.15
+40.58%
-330.08
Common Stock Issuance
—
—
—
0.00
Earnings Losses From Equity Investments
107.61
+564.21%
16.20
+6794.63%
-0.24
+94.99%
-4.83
Issuance Of Capital Stock
—
—
—
0.00
Other Cash Adjustment Outside Changein Cash
—
0.00
0.00
+100.00%
-0.61
Sale Of Business
—
0.00
0.00
-100.00%
272.59
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category